Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
A phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis
The first three stages are also called non-REM (NREM) sleep
Jiang, N., Doseff, A
Because this is still an investigational compound, we frame the science honestly: what is genuinely studied, and what remains unknown
.jpg)
US$ 25.36
US$ 28.97
US$ 22.88
US$ 27.54
US$ 26.95
